Related Experiment Video
Updated: Oct 21, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Gastric Cancer in Iran: An Overview of Risk Factors and Preventive Measures
Elham Akbarpour1, Alireza Sadjadi1, Mohammad H Derakhshan2
1Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Gastric cancer (GC) remains a major health issue, especially in Iran. Identifying region-specific risk factors like hookah and opium use is key for early detection and prevention strategies.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Gastric cancer (GC) persists as a significant global health challenge and a leading cause of cancer mortality.
- Early diagnosis and prevention are crucial, as GC is often detected at advanced stages.
- Current screening methods like endoscopy are invasive and costly, necessitating more efficient regional strategies.
Purpose of the Study:
- To review current knowledge on gastric cancer.
- To present data from newly-established Population-based Cancer Registries (PBCRs) in Iran.
- To identify region-specific risk factors for gastric cancer in Iran.
Main Methods:
- Review of existing gastric cancer literature.
- Analysis of data from Iranian Population-based Cancer Registries (PBCRs).
Main Results:
- Confirmed very high GC incidence rates in northwestern and northern Iranian provinces, particularly Ardabil.
- Highlighted conventional risk factors: Helicobacter pylori (HP) infection and high salt intake.
- Identified novel region-specific risk factors: hookah and opium use.
Conclusions:
- Modifying behavioral and environmental risk factors, alongside advancing biomarkers, offers the best approach for large-scale reduction in GC incidence and mortality.
- Endoscopic screening and antibiotic chemoprophylaxis for HP remain vital for high-risk individuals meeting specific criteria.
Related Concept Videos
Cancer Prevention
Some...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

